Familial pulmonary arterial hypertension by
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
07
11
2019
accepted:
02
01
2020
pubmed:
26
1
2020
medline:
22
6
2021
entrez:
26
1
2020
Statut:
epublish
Résumé
Beyond the major gene
Identifiants
pubmed: 31980491
pii: 13993003.02165-2019
doi: 10.1183/13993003.02165-2019
pii:
doi:
Substances chimiques
KDR protein, human
EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-2
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : British Heart Foundation
ID : CH/09/001/25945
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K020919/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright ©ERS 2020.
Déclaration de conflit d'intérêts
Conflict of interest: M. Eyries has nothing to disclose. D. Montani reports grants and personal fees from Actelion and Bayer, personal fees from GSK, Pfizer and MSD, outside the submitted work. Conflict of interest: B. Girerd has nothing to disclose. Conflict of interest: N. Favrolt has nothing to disclose. Conflict of interest: M. Riou has nothing to disclose. Conflict of interest: L. Faivre has nothing to disclose. Conflict of interest: G. Manaud has nothing to disclose. Conflict of interest: F. Perros has nothing to disclose. Conflict of interest: S. Gräf has nothing to disclose. Conflict of interest: M.W. Morrell is an employee of Morphogen-IX. Conflict of interest: M. Humbert reports personal fees from Acceleron, Actelion, Merck and United Therapeutics, grants and personal fees from Bayer and GSK, outside the submitted work. Conflict of interest: F. Soubrier has nothing to disclose.